The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.

Start Codon, a healthcare and life sciences accelerator backed by Cambridge Innovation Capital (CIC), the venture capital investor focused on the Cambridge, UK ecosystem, has raised £15m ($20m) for its first venture capital fund. The raise was announced yesterday and represents a final close. In addition to CIC, limited partners include pharmaceutical firm Novartis, which…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.